KLK3 and cancer: Overdiagnosis is another well-known problem in the oncology literature for controversial cancer screening tests which aim at early cancer detection such as mammography and prostate-specific antigen screening [107], and refers to the detection of subclinical disease (sometimes called pseudodisease) which would not have become manifest clinically in someone’s remaining lifetime [108, 109].